SERA PROGNOSTICS, INC. Stock-Based Compensation
SERA PROGNOSTICS, INC. (SERA) reported Stock-Based Compensation of $1.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $823.00K, a 38.76% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $835.00K, a 44.07% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.02M, a 36.98% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.25M, a 25.36% decline year-over-year.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $5.11M, a 27.14% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $7.01M, a 33.00% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.27M, a 4.31% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.05M, a 61.50% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $823.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.66M 10-Q · filed 2026-08-12 | $2.68M derived: sum of 3 quarters · filed 2026-08-12 | $3.93M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $835.00K 10-Q · filed 2026-05-06 | $1.85M derived: sum of 2 quarters · filed 2026-05-06 | $3.11M derived: sum of 3 quarters · filed 2026-05-06 | $4.45M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.27M derived: sum of 2 quarters · filed 2026-03-18 | $3.62M derived: sum of 3 quarters · filed 2026-08-12 | $5.11M 10-K · filed 2026-03-18 |
| 2025-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.60M derived: sum of 2 quarters · filed 2026-08-12 | $4.09M 10-Q · filed 2025-11-13 | $5.71M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.84M 10-Q · filed 2026-08-12 | $4.45M derived: sum of 3 quarters · filed 2026-08-12 | $6.13M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.49M 10-Q · filed 2026-05-06 | $3.11M derived: sum of 2 quarters · filed 2026-05-06 | $4.79M derived: sum of 3 quarters · filed 2026-05-06 | $6.81M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $3.30M derived: sum of 2 quarters · filed 2026-03-18 | $5.32M derived: sum of 3 quarters · filed 2026-03-18 | $7.01M 10-K · filed 2026-03-18 |
| 2024-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.70M derived: sum of 2 quarters · filed 2025-11-13 | $5.40M 10-Q · filed 2025-11-13 | $6.74M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.72M 10-Q · filed 2025-08-06 | $5.06M derived: sum of 3 quarters · filed 2025-08-06 | $6.25M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-07 | $3.04M derived: sum of 2 quarters · filed 2025-05-07 | $4.22M derived: sum of 3 quarters · filed 2025-05-07 | $5.66M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $2.53M derived: sum of 2 quarters · filed 2025-03-19 | $3.97M derived: sum of 3 quarters · filed 2025-03-19 | $5.27M 10-K · filed 2025-03-19 |
| 2023-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.62M derived: sum of 2 quarters · filed 2024-11-06 | $3.93M 10-Q · filed 2024-11-06 | $5.27M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.74M 10-Q · filed 2024-08-07 | $4.08M derived: sum of 3 quarters · filed 2024-08-07 | $5.36M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-08 | $2.65M derived: sum of 2 quarters · filed 2024-05-08 | $3.92M derived: sum of 3 quarters · filed 2024-05-08 | $5.14M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $2.62M derived: sum of 2 quarters · filed 2024-03-20 | $3.83M derived: sum of 3 quarters · filed 2024-03-20 | $5.05M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.49M derived: sum of 2 quarters · filed 2023-11-08 | $3.71M 10-Q · filed 2023-11-08 | $4.83M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.44M 10-Q · filed 2023-08-09 | $3.55M derived: sum of 3 quarters · filed 2023-08-09 | $4.46M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.22M 10-Q · filed 2023-05-10 | $2.33M derived: sum of 2 quarters · filed 2023-05-10 | $3.25M derived: sum of 3 quarters · filed 2023-05-10 | $4.11M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $2.03M derived: sum of 2 quarters · filed 2023-03-22 | $2.89M derived: sum of 3 quarters · filed 2023-03-22 | $3.13M 10-K · filed 2023-03-22 |
| 2021-09-30 | $914.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.78M derived: sum of 2 quarters · filed 2022-11-09 | $2.02M 10-Q · filed 2022-11-09 | $2.21M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.10M 10-Q · filed 2022-08-10 | $1.30M derived: sum of 3 quarters · filed 2022-08-10 | $1.49M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $239.00K 10-Q · filed 2022-05-10 | $434.00K derived: sum of 2 quarters · filed 2022-05-10 | $629.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $390.00K derived: sum of 2 quarters · filed 2022-03-29 | $726.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $531.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $336.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |